The Burden of Arthritis and Nonsteroidal Anti-Inflammatory Treatment Elke HunscheJeremy V. M. ChancellorNick Bruce Review Article 29 September 2012 Pages: 1 - 15
Healthcare Resource Utilisation and Costs of Treating NSAID-Associated Gastrointestinal Toxicity Catherine ChevatBeatriz M. PeñaFrans F. H. Rutten Original Research Article 29 September 2012 Pages: 17 - 32
A Framework for Evaluating the Clinical Consequences of Initial Therapy with NSAIDs, NSAIDs plus Gastroprotective Agents, or Celecoxib in the Treatment of Arthritis Thomas A. BurkeRichard A. ZabinskiJay L. Goldstein Original Research Article 29 September 2012 Pages: 33 - 47
An Economic Model for Determining the Costs and Consequences of Using Various Treatment Alternatives for the Management of Arthritis in Canada Richard A. ZabinskiThomas A. BurkeJeremy V. M. Chancellor Original Research Article 29 September 2012 Pages: 49 - 58
Economic Evaluation of Celecoxib, a New Cyclo-Oxygenase 2 Specific Inhibitor, in Switzerland Jeremy V. M. ChancellorElke HunscheFrançois P. Sarasin Original Research Article 29 September 2012 Pages: 59 - 75